Xylem (XYL) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
1 Dec, 2025Executive summary
Annual meeting scheduled for May 13, 2025, with virtual participation available to shareholders.
Shareholders are encouraged to review proxy materials and vote on key proposals by May 12, 2025.
Voting matters and shareholder proposals
Election of nine directors is up for shareholder approval, with board recommending all nominees.
Ratification of Deloitte & Touche LLP as independent auditor for fiscal year ending December 31, 2025.
Advisory vote on executive compensation (say-on-pay) is recommended for approval.
Shareholder proposal to lower the threshold for calling special meetings from 25% to 10% of stock, with board recommending a vote against.
Board of directors and corporate governance
Nine individuals nominated for board positions, including both current and new members.
Board provides recommendations for each voting item to guide shareholder decisions.
Latest events from Xylem
- Record 2025 results, margin gains, and strong 2026 outlook despite top-line headwinds.XYL
Q4 202510 Feb 2026 - Board and auditor approvals, strong financials, and strategic progress marked the meeting.XYL
AGM 20253 Feb 2026 - Q2 revenue up 26%, margin expansion, and raised 2024 guidance on strong demand.XYL
Q2 20242 Feb 2026 - Margin expansion and synergy gains drive growth, backed by strong financial flexibility.XYL
The Stifel 2024 Cross Sector Insight Conference31 Jan 2026 - Record Q3 profit, margin gains, and strong orders support a raised full-year outlook.XYL
Q3 202417 Jan 2026 - Record results and 2025 guidance highlight growth, margin expansion, and ongoing transformation.XYL
Q4 20248 Jan 2026 - Q1 2025 delivered 2% revenue growth, margin expansion, and reaffirmed full-year guidance.XYL
Q1 202526 Dec 2025 - Record financials, new ESG targets, and board refreshment highlight this year's proxy.XYL
Proxy Filing1 Dec 2025 - Q2 2025 saw record margin and EPS growth, prompting raised full-year guidance.XYL
Q2 20255 Nov 2025